153 related articles for article (PubMed ID: 35544035)
41. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
[TBL] [Abstract][Full Text] [Related]
42. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.
Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C
J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517
[TBL] [Abstract][Full Text] [Related]
43. Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy.
Donovan LE; Arnal AV; Wang SH; Odia Y
CNS Oncol; 2016 Oct; 5(4):203-9. PubMed ID: 27615706
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study.
Majd N; Waguespack SG; Janku F; Fu S; Penas-Prado M; Xu M; Alshawa A; Kamiya-Matsuoka C; Raza SM; McCutcheon IE; Naing A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33427689
[TBL] [Abstract][Full Text] [Related]
45. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
Negm HM; Al-Mahfoudh R; Pai M; Singh H; Cohen S; Dhandapani S; Anand VK; Schwartz TH
J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
[TBL] [Abstract][Full Text] [Related]
46. Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.
Greenman Y; Cooper O; Yaish I; Robenshtok E; Sagiv N; Jonas-Kimchi T; Yuan X; Gertych A; Shimon I; Ram Z; Melmed S; Stern N
Eur J Endocrinol; 2016 Jul; 175(1):63-72. PubMed ID: 27150495
[TBL] [Abstract][Full Text] [Related]
47. A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report.
Murakami M; Mizutani A; Asano S; Katakami H; Ozawa Y; Yamazaki K; Ishida Y; Takano K; Okinaga H; Matsuno A
Neurosurgery; 2011 Jun; 68(6):E1761-7; discussion E1767. PubMed ID: 21389894
[TBL] [Abstract][Full Text] [Related]
48. Molecular Profile of a Pituitary Rhabdomyosarcoma Arising From a Pituitary Macroadenoma: A Case Report.
Lu J; Chen L
Front Endocrinol (Lausanne); 2021; 12():752361. PubMed ID: 34659131
[TBL] [Abstract][Full Text] [Related]
49. The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite.
Zaidi HA; De Los Reyes K; Barkhoudarian G; Litvack ZN; Bi WL; Rincon-Torroella J; Mukundan S; Dunn IF; Laws ER
Neurosurg Focus; 2016 Mar; 40(3):E18. PubMed ID: 26926058
[TBL] [Abstract][Full Text] [Related]
50. Immunotherapy in pituitary carcinomas and aggressive pituitary tumors.
Raverot G; Ilie MD
Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101712. PubMed ID: 36274025
[TBL] [Abstract][Full Text] [Related]
51. Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
Bengtsson D; Schrøder HD; Andersen M; Maiter D; Berinder K; Feldt Rasmussen U; Rasmussen ÅK; Johannsson G; Hoybye C; van der Lely AJ; Petersson M; Ragnarsson O; Burman P
J Clin Endocrinol Metab; 2015 Apr; 100(4):1689-98. PubMed ID: 25646794
[TBL] [Abstract][Full Text] [Related]
52. A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report.
Remón-Ruiz P; Venegas-Moreno E; Dios-Fuentes E; Moreno JMC; Fernandez Peña I; Garcia MA; Japón-Rodriguez MA; Roldán F; Fajardo E; Kaen A; Ruiz-Valdepeñas EC; Cano D; Soto-Moreno A
Front Endocrinol (Lausanne); 2021; 12():784889. PubMed ID: 34992581
[TBL] [Abstract][Full Text] [Related]
53. Mixed gangliocytoma-pituitary adenoma in the sellar region: a large-scale single-center experience.
Yang B; Yang C; Sun Y; Du J; Liu P; Jia G; Jia W; Zhang Y; Wang J; Xu Y; Wang S
Acta Neurochir (Wien); 2018 Oct; 160(10):1989-1999. PubMed ID: 30109498
[TBL] [Abstract][Full Text] [Related]
54. Pharyngeal pituitary non-functioning adenoma with normal intra-sellar gland: massive tumor shrinkage on octreotide therapy.
Pugnale N; Waridel F; Bouzourène H; Boubaker A; Pugnale M; Gaillard RC; Gomez F
Eur J Endocrinol; 2003 Mar; 148(3):357-64. PubMed ID: 12611618
[TBL] [Abstract][Full Text] [Related]
55. Aggressive corticotroph tumors and carcinomas.
Lasolle H; Vasiljevic A; Jouanneau E; Ilie MD; Raverot G
J Neuroendocrinol; 2022 Aug; 34(8):e13169. PubMed ID: 35979732
[TBL] [Abstract][Full Text] [Related]
56. The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic and Microsurgical Transsphenoidal Pituitary Adenoma Resection.
Pal'a A; Knoll A; Brand C; Etzrodt-Walter G; Coburger J; Wirtz CR; Hlaváč M
World Neurosurg; 2017 Jun; 102():144-150. PubMed ID: 28286276
[TBL] [Abstract][Full Text] [Related]
57. The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence.
Almeida JP; Tabasinejad R; Kalyvas A; Takami H; Mohan N; O'Halloran PJ; Sanchez MM; Velasquez C; Zadeh G; Gentili F
Neurol India; 2020; 68(Supplement):S92-S100. PubMed ID: 32611898
[TBL] [Abstract][Full Text] [Related]
58. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
[TBL] [Abstract][Full Text] [Related]
59. Results and risk factors for recurrence following endoscopic endonasal transsphenoidal surgery for pituitary adenoma.
Bodhinayake I; Ottenhausen M; Mooney MA; Kesavabhotla K; Christos P; Schwarz JT; Boockvar JA
Clin Neurol Neurosurg; 2014 Apr; 119():75-9. PubMed ID: 24635930
[TBL] [Abstract][Full Text] [Related]
60. Treatment of pituitary neoplasms with temozolomide: a review.
Syro LV; Ortiz LD; Scheithauer BW; Lloyd R; Lau Q; Gonzalez R; Uribe H; Cusimano M; Kovacs K; Horvath E
Cancer; 2011 Feb; 117(3):454-62. PubMed ID: 20845485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
